US Diabetes Market Report 2016

8/17/2019 US Diabetes Market Report 2016

http://slidepdf.com/reader/full/us-diabetes-market-report-2016 1/12

Imarc www.imarcgroup.com

Consulting Services

Copyright © 2016 International Market Analysis esearch ! Consulting "IMAC#. All ights eserve$

US DiabetesMarket Report:

2016 - 2020



The International Market Analysis Research and Consulting Group is a leadingadvisor on management strategy and market research worldwide. We partner withclients in all sectors and regions to identify their highestvalue opportunities!address their most critical challenges! and transform their "usinesses.

IMARC#s information products include ma$or market! scienti%c! economic and

technological developments for "usiness leaders in pharmaceutical! industrial! andhigh technology organi&ations. Market forecasts and industry analysis for"iotechnology! advanced materials! pharmaceuticals! food and "everage! traveland tourism! nanotechnology and novel processing methods are at the top of thecompany#s e'pertise.

IMARC#s tailored approach com"ines unfathoma"le insight into the dynamics of

companies and markets with close cooperation at all levels of the clientorgani&ation. This ensures that our clients achieve unmatcha"le competitiveadvantage! "uild more pro%cient organi&ations! and secure lasting results.

Report Description

About IMARC GroupImarc www.imarcgroup.com



Report Description

Report Description and Hig!igtsImarc www.imarcgroup.com

US Diabetes Market 2016 " #rends$ Demograpica! break%p$ Diagnosisand #reatments and &orecasts

IMARC#s new report 'US Diabetes Market Report: 2016 - 2020( provides an analyticaland statistical insight into the )* dia"etes market. The report provides "oth current andfuture trends in the prevalence! demographical "reakup! diagnosis and treatment ofdia"etes in the )nited *tates. The research study serves as an e'ceptional tool tounderstand the epidemiology! market trends! therapeutic structure! competitive structureand the outlook of the )* dia"etes market. This report can serve as an e'cellent guide for

investors! researchers! consultants! marketing strategists and all those who are planningto foray into the )* dia"etes market in any form.

)at *e a+e acie+ed in tis report:Compreensi+e sit%ation ana!,sis o te US diabetes epidemio!og, and itsd,namics:&oc%s o te Ana!,sis:

• +istorical! current and future prevalence of dia"etes in )*• +istorical! current and future prevalence of type, and type- dia"etes in )*• +istorical! current and future prevalence of dia"etes in the ur"an and rural regions in

)*• +istorical! current and future prevalence of dia"etes among males and females in )*• +istorical! current and future prevalence of dia"etes among various age groups in )*• +istorical! current and future diagnosis rates for dia"etes in )*•

+istorical! current and future drug treatment rates for dia"etes in )*



Report Description


Compreensi+e sit%ation ana!,sis o te US .ra! Antidiabetics market and itsd,namics:

&oc%s o te Ana!,sis:

• erformance of the /ral Antidia"etics market in )*• erformance of key classes• erformance of key players• Market outlook

Compreensi+e sit%ation ana!,sis o te US Ins%!in market and its d,namics:

&oc%s o te Ana!,sis:

• erformance of the Insulin market in )*• erformance of key classes• erformance of key players

• Market outlook



US Diabetes MarketImarc www.imarcgroup.com



Report Description


#ab!e o Contents

1 Researc Metodo!og,

2 /ec%ti+e S%mmar, Diabetes Disease .+er+ie*0., What is 1ia"etes20.- 1ia"etes 1iagnosis and Treatment0.-., 1iagnosis0.-.- Treatment0.0 1ia"etes Complications

3e, &actors Dri+ing te Diabetes Market in US4 US Diabetes /pidemio!og,3., 1ia"etes opulation and revalence Rates3.- opulation and revalence Rates "y 1ia"etes Type 4Type, and Type-53.0 opulation and revalence Rates "y Region3.6 opulation and revalence Rates "y Gender3.3 opulation and revalence Rates "y Age Group6 US Diabetes Market

7., +istorical Market Trends7.- Market /utlook7.0 Market 8reakup "y *egment7.6 )* /ral Antidia"etics Market7.6., +istorical Market Trends7.6.- Market 8reakup "y Class



Report DescriptionReport Description and Hig!igtsImarc

www.imarcgroup.com

7.6.0 Market *hares of 9ey layers7.6.6 Market /utlook

7.3 )* Insulin Market7.3., +istorical Market Trends7.3.- Market 8reakup "y Class7.3.0 Market *hares of 9ey layers7.3.6 Market /utlook

5ist o &ig%res

:igure 0 ,; The impact of 1ia"etes in the +uman 8ody:igure 0 -; 1ia"etes Complications:igure 6 ,; Glo"al; 8reakup of 1ia"etes atients "y Region! 4in <5 -=,3 > -=03:igure 6 -; )*; /verweight > /"ese opulation? 4in Million5! -=,=! -=,3 > -=-=:igure 6 0; 8ody Mass Inde' and Relative risk of Type- 1ia"etes:igure 6 6; )*; 8reakup of Total opulation "y Age Groups 4=,6! ,376 > 73@5! 4in <5:igure 6 3; )*; 1ia"etes revalence 8y Age Groups! 4in <5

:igure 3 ,; )*; Total um"er of 1ia"etes atients? 4in ===5! -==B-=,3:igure 3 -; )*; Total um"er of 1ia"etes atients? :orecast 4in ===5! -=,7-=-=:igure 3 0; )* 4Type, > Type-5; Total um"er of 1ia"etes atients? 4in ===5! -==B -=,3:igure 3 6; )* 4Type, > Type-5; Total um"er of 1ia"etes atients? 4in ===5!-=,7-=-=:igure 3 3; )* 4)r"an > Rural5; Total um"er of 1ia"etes atients? 4in ===5! -==B -=,3:igure 3 7; )* 4)r"an > Rural5; Total um"er of 1ia"etes atients? 4in ===5! -=,7 -=-=




www.imarcgroup.com

:igure 3 ; )* 4Male > :emale5; Total um"er of 1ia"etes atients? 4in ===5! -==B -=,3:igure 3 B; )* 4Male > :emale5; Total um"er of 1ia"etes atients? 4in ===5! -=,7 -=-=

:igure 3 D; )*; Total um"er of 1ia"etes atients "y Age Group 4-=0D5! 46=3D5 > 47=D54in ===5! -==B -=,3:igure 3 ,=; )*; Total um"er of 1ia"etes atients "y Age Group 4-=0D5! 46=3D5 > 47=D5 4in ===5! -=,7 -=-=:igure 7 ,; )*; 1ia"etes 1rugs Market 4in Million )*E5! -==B -=,3:igure 7 -; )*; 1ia"etes 1rug Market :orecast 4in Million )*E5! -=,7 -=-=:igure 7 0; )*; 1ia"etes 1rugs Market; 8reakup of Insulin and /ral Antidia"etics 4in <5!

-==B -=,3:igure 7 6; )*; 1ia"etes 1rugs Market :orecast; 8reakup of Insulin and /ral Antidia"etics4in <5! -=,7 -=-=:igure 7 3; )*; /ral Antidia"etics Market; 4in Million )*E5! -==B -=,3:igure 7 7; )*; /ral Antidia"etics Market; *ales *hare of 9ey Classes 4in <5! -==B > -=,3:igure 7 ; )*; /ral Antidia"etics Market; *ales *hare of 9ey layers 4in <5:igure 7 B; )*; /ral Antidia"etics Market; 4in Million )*E5! -=,7 -=-=:igure 7 D; )*; /ral Antidia"etics Market; *ales *hare of 9ey Classes 4in <5! -=,7 > -=-=

:igure 7 ,=; )*; Insulin Market! 4in Million )*E5! -==B -=,3:igure 7 ,,; )*; 8reakup of Insulin Market "y Class 4in <5:igure 7 ,-; )*; Insulin Market; *ales *hare of 9ey layers 4in <5:igure 7 ,0; )*; Insulin Market :orecast 4in Million )*E5! -=,7 -=-=




www.imarcgroup.com

5ist o #ab!es

Ta"le 0 ,; 1iagnosis of 1ia"etes Ta"le 6 ,; Glo"al; 1ia"etes opulation 8reakup "y Country 4in ===#s5! -=,3 > -=03 Ta"le 6 -; )*; /verweight >/"esity *tatistics! -=,=! -=,3 > -=-= Ta"le 6 0; )*; 8reakup of Total opulation "y Age Groups 4=,6! ,376 > 73@5! 4in Million5 Ta"le 3 ,; )*; Total revalence > um"er of 1ia"etes atients?! -==B! -=,3 > -=-= Ta"le 3 -; )* 4Type, > Type-5; Total revalence > um"er of 1ia"etes atients! -==B! -=,3> -=-=

Ta"le 3 0; )* 4)r"an > Rural5; Total revalence > um"er of 1ia"etes atients! -==B! -=,3> -=-=

Ta"le 3 6; )* 4Male > :emale5; Total revalence > um"er of 1ia"etes atients! -==B!-=,3 > -=-=

Ta"le 3 3; Total revalence > um"er of 1ia"etes atients "y Age Group 4-=0D5! 46=3D5 >47=D5 4In Millions5! -==B! -=,3 > -=-=




www.imarcgroup.com

#o b%, te comp!ete report or to get a ree samp!e$ p!ease contact:

IMARC 7ro%p Asia:Fmail; apacimarcgroup.comhone; @D,,-=6,33=DD

IMARC 7ro%p 8ort America:Fmail; americaimarcgroup.comhone; @,70,D,,,63

IMARC 7ro%p /%rope$ Midd!e /ast 9 Arica:Fmail;emaimarcgroup.comhone; @66=-6=D00,

#o kno* more p!ease +isit: http;HHwww.imarcgroup.comH)*dia"etesmarket

http://www.imarcgroup.com/US-diabetes-market

http://www.imarcgroup.com/US-diabetes-market




www.imarcgroup.com

© 2016 IMARC A!! Rigts Reser+ed

This u"lication and all it#s contents unless otherwise mentioned are copyrighted in thename of International Market Analysis Research and Consulting 4IMARC5. o part of thispu"lication may "e reproduced! repackaged! redistri"uted or resold in whole or in anypart. The pu"lication may also not "e used in any form or "y and means graphicelectronic or mechanical! including photocopying! recording! taping or "y information

storage or retrieval! or "y any other form! without the e'press consent of InternationalMarket Analysis Research and Consulting 4IMARC5.

Disc!aimer: All contents and data of this pu"lication! including forecasts! data analysisand opinion have "een "ased on information and sources "elieved to "e accurate andrelia"le at the time of pu"lishing. International Market Analysis Research andConsulting makes no representation of warranty of any kind as to the accuracy or

completeness of any Information provided. IMARC accepts no lia"ility whatsoever forany loss or damage resulting from opinion! errors or inaccuracies if any found thispu"lication.

IMARC! IMARC Group and Glo"al Therapy Insight *eries are registered trademarks ofInternational Market Analysis Research and Consulting. All other trademarks used inthis pu"lication are registered trademarks of their respective companies.



:/R M/RF1FTAI*isit %s

at :

Sta, )itUs:

TELEPHONE: +91-120-4155099

E-MAIL: sales@imarcgr!"#cm

ttp:;;***<imarcgro%p<com

Contact Us

http://www.imarcgroup.com/



Documents

US Diabetes Market Report 2016